{"id":"https://openalex.org/W2182402980","doi":null,"title":"KETAMINE FOR DEPRESSION: AN OLD DRUG WITH A NEW INDICATION","display_name":"KETAMINE FOR DEPRESSION: AN OLD DRUG WITH A NEW INDICATION","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2182402980","mag":"2182402980"},"language":"en","primary_location":{"id":"mag:2182402980","doi":null,"is_oa":false,"landing_page_url":"http://www.clinicalneuropsychiatry.org/pdf/SchepisiP.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080777409","display_name":"Chiara Schepisi","orcid":"https://orcid.org/0000-0001-8354-6305","observed_orcids":["https://orcid.org/0000-0001-8354-6305"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiara Schepisi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8354-6305","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112784201","display_name":"Diletta Sabatini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diletta Sabatini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032085665","display_name":"Paolo Nencini","orcid":"https://orcid.org/0009-0000-9247-2168","observed_orcids":["https://orcid.org/0009-0000-9247-2168","https://orcid.org/0000-0001-9712-5421"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Nencini","raw_affiliation_strings":["Sapienza University of Rome"],"raw_orcid":"https://orcid.org/0000-0001-9712-5421","affiliations":[{"raw_affiliation_string":"Sapienza University of Rome","institution_ids":["https://openalex.org/I861853513"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2203,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.53148469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10614","display_name":"Transcranial Magnetic Stimulation Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9480000138282776},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.996999979019165},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.9459999799728394},{"id":"https://openalex.org/keywords/glutamatergic-system","display_name":"glutamatergic system","score":0.8830000162124634},{"id":"https://openalex.org/keywords/rapid-acting-antidepressants","display_name":"rapid-acting antidepressants","score":0.7900000214576721},{"id":"https://openalex.org/keywords/ketamine-induced-psychosis","display_name":"ketamine-induced psychosis","score":0.5490000247955322},{"id":"https://openalex.org/keywords/ketamine-abuse","display_name":"ketamine abuse","score":0.4569999873638153},{"id":"https://openalex.org/keywords/ketamine-analogues","display_name":"ketamine analogues","score":0.503000020980835},{"id":"https://openalex.org/keywords/ketamine-derivatives","display_name":"ketamine derivatives","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7530068159103394},{"id":"https://openalex.org/C2777342061","wikidata":"https://www.wikidata.org/wiki/Q7836891","display_name":"Treatment-resistant depression","level":4,"score":0.6682809591293335},{"id":"https://openalex.org/C2777330709","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive therapy","level":3,"score":0.6674987077713013},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6314609050750732},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.585422694683075},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5554335713386536},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5320088863372803},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4757525622844696},{"id":"https://openalex.org/C2781210005","wikidata":"https://www.wikidata.org/wiki/Q6738337","display_name":"Major depressive episode","level":3,"score":0.46481049060821533},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.45377522706985474},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.4322274327278137},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3845110237598419},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.23267310857772827},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2245543897151947},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2182402980","doi":null,"is_oa":false,"landing_page_url":"http://www.clinicalneuropsychiatry.org/pdf/SchepisiP.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W1558342067","https://openalex.org/W1924706543","https://openalex.org/W1964466640","https://openalex.org/W1980807324","https://openalex.org/W1995653940","https://openalex.org/W1999600703","https://openalex.org/W2000388202","https://openalex.org/W2004267297","https://openalex.org/W2006374396","https://openalex.org/W2018114814","https://openalex.org/W2020235530","https://openalex.org/W2020844317","https://openalex.org/W2028423021","https://openalex.org/W2028884770","https://openalex.org/W2032057219","https://openalex.org/W2032187584","https://openalex.org/W2033045687","https://openalex.org/W2037792618","https://openalex.org/W2043644289","https://openalex.org/W2046970066","https://openalex.org/W2047426512","https://openalex.org/W2052665050","https://openalex.org/W2067391748","https://openalex.org/W2067495470","https://openalex.org/W2071199266","https://openalex.org/W2075033894","https://openalex.org/W2080357839","https://openalex.org/W2089351762","https://openalex.org/W2091363925","https://openalex.org/W2092634437","https://openalex.org/W2093284812","https://openalex.org/W2093531409","https://openalex.org/W2093795230","https://openalex.org/W2097857685","https://openalex.org/W2098254992","https://openalex.org/W2100344731","https://openalex.org/W2103255996","https://openalex.org/W2108914738","https://openalex.org/W2111028594","https://openalex.org/W2114613490","https://openalex.org/W2123488676","https://openalex.org/W2131823335","https://openalex.org/W2133025757","https://openalex.org/W2138517367","https://openalex.org/W2139637981","https://openalex.org/W2140606211","https://openalex.org/W2152644978","https://openalex.org/W2157504436","https://openalex.org/W2158714604","https://openalex.org/W2159388055","https://openalex.org/W2167659819","https://openalex.org/W2172219833","https://openalex.org/W2314124374"],"related_works":["https://openalex.org/W1568032404","https://openalex.org/W2026730082","https://openalex.org/W1993254026","https://openalex.org/W2158031806","https://openalex.org/W2320192897","https://openalex.org/W2801076592","https://openalex.org/W4388308521","https://openalex.org/W3097055675","https://openalex.org/W4363648521","https://openalex.org/W4205833945"],"abstract_inverted_index":{"Major":[0],"depressive":[1],"disorder":[2],"(MDD)":[3],"is":[4,28,47,108,202,270],"a":[5,86,156,203,237,271,398],"severe":[6],"and":[7,62,83,105,134,145,177,284,322,345],"chronic":[8],"condition":[9],"affecting":[10],"350":[11],"million":[12,17],"subjects":[13,18],"worldwide":[14],"with":[15,275,397],"1":[16,104],"committing":[19],"suicide":[20],"every":[21],"year":[22],"(World":[23],"Health":[24],"Organization":[25],"2008).":[26,331],"MDD":[27,114,344],"prevailing":[29],"in":[30,59,263,296],"wealthy":[31],"countries":[32],"including":[33],"Italy,":[34],"where":[35],"lifetime":[36],"prevalence":[37],"was":[38],"estimated":[39],"at":[40,51,78,165,193],"9.9%":[41],"(Bromet":[42],"et":[43,210,278,304,308,312,325,329,355,359,363,367,371,375,380],"al.":[44,279,305,309,313,326,330,356,360,364,368,372,376,381],"2011).":[45],"Diagnosis":[46],"defined":[48,188],"by":[49,298],"fulfilling":[50],"least":[52,79,166,194],"five":[53],"of":[54,65,94,99,113,123,158,164,174,179,192,216,338,343,394,405],"the":[55,60,92,111,175,190,334,341,386,391,402],"nine":[56],"criteria":[57],"described":[58],"Diagnostic":[61],"statistical":[63],"manual":[64],"mental":[66],"disorders":[67],"(DMS-5;":[68],"American":[69,116],"Psychiatric":[70,117],"Association":[71,118],"2013).":[72,119,288,382],"Symptoms":[73],"should":[74,84],"be":[75],"present":[76],"for":[77,110,129,206,240,318,340],"2":[80,167],"consecutive":[81],"weeks":[82],"\u201crepresent":[85],"change":[87],"from":[88,132,198],"previous":[89],"functioning\u201d.":[90],"Moreover,":[91],"presence":[93],"\u201cdepressed":[95],"mood\u201d":[96],"or":[97,101,172],"\u201closs":[98],"interest":[100],"pleasure\u201c":[102],"(criteria":[103],"2,":[106],"respectively)":[107],"mandatory":[109],"diagnosis":[112],"(DSM-5;":[115],"A":[120,213],"wide":[121],"array":[122],"treatment":[124,183,342],"options":[125],"are":[126,316],"currently":[127],"available":[128],"MDD,":[130],"spanning":[131],"pharmacotherapy":[133],"psychotherapy":[135],"to":[136,182,221,253],"their":[137],"combination,":[138],"as":[139,141,189,244,246],"well":[140],"electroconvulsive":[142],"therapy":[143],"(ECT)":[144],"transcranial":[146],"magnetic":[147],"stimulation":[148],"(TMS).":[149],"Despite":[150,289],"all":[151],"these":[152],"therapeutic":[153,224],"options,":[154],"only":[155],"fraction":[157],"patients":[159],"achieves":[160],"remission":[161],"(a":[162],"period":[163],"months":[168],"without":[169],"significant":[170],"signs":[171],"symptoms":[173,180],"disease)":[176],"chronicity":[178],"predisposes":[181],"resistance.":[184],"Treatment-resistant":[185],"depression":[186,347],"(TRD),":[187],"failure":[191],"two":[195,199],"antidepressant":[196,257,392],"treatments":[197],"different":[200],"classes,":[201],"major":[204],"concern":[205],"public":[207],"health":[208],"(Souery":[209],"al":[211],"2006).":[212],"great":[214],"deal":[215],"research":[217],"has":[218,250,260,349],"been":[219,251,261,350],"addressed":[220],"develop":[222],"new":[223,266],"strategies":[225],"based":[226],"on":[227,390,401],"innovative":[228],"psychopharmacological":[229],"approaches.":[230],"In":[231],"this":[232,265],"frame,":[233],"glutamatergic":[234],"system":[235],"represents":[236],"promising":[238,291],"target":[239],"an":[241],"effective":[242],"intervention":[243],"long":[245],"NMDA":[247,273],"receptor":[248],"antagonism":[249],"found":[252],"produce":[254],"fast":[255],"acting":[256],"effects.":[258],"Ketamine":[259],"instrumental":[262],"developing":[264],"concept.":[267],"This":[268],"drug":[269],"non-selective":[272],"antagonist":[274],"anaesthetic":[276],"(Marland":[277],"2013),":[280],"analgesic":[281],"(Persson":[282],"2013)":[283],"anticonvulsivant":[285],"properties":[286],"(Dorandeu":[287],"its":[290,319],"clinical":[292,336],"application,":[293],"ketamine":[294,339],"use":[295,321,337],"limited":[297],"potentially":[299],"harmful":[300],"psychotomimetic":[301],"effects":[302],"(Krystal":[303],"1994,":[306],"Lahti":[307],"1995,":[310],"Moore":[311],"2011)":[314],"which":[315],"responsible":[317],"recreational":[320],"abuse":[323],"(Morgan":[324],"2004,":[327],"Muetzelfeldt":[328],"More":[332],"recently,":[333],"potential":[335,403],"bipolar":[346],"(BD)":[348],"evaluated":[351],"(Aan":[352],"Het":[353],"Rot":[354],"2010,":[357,361],"Messer":[358],"Blier":[362],"2012,":[365,369],"Cusin":[366],"Krystal":[370],"2013,":[373],"Murrough":[374],"2013":[377],"a,c,":[378],"Niciu":[379],"Hereafter":[383],"we":[384],"summarize":[385],"most":[387],"recent":[388],"findings":[389],"activity":[393],"ketamine,":[395],"together":[396],"brief":[399],"update":[400],"mechanism":[404],"action.":[406]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}